AIDS

1. PAGKAS-BATHER JV, Motley DN, Balthazar C, Schneider JA, et al
   BIG Cuts, BIG Solutions: The Case for Basic Income Guarantee for Low Income People with HIV.
   AIDS. 2026 Feb 12. doi: 10.1097/QAD.0000000000004460.
   

   >> Share

   
   
2. JAIN A, Liou ML, Xiao L, Canepa GE, et al
   Impact of AGT103-T cell and gene therapy on intact HIV proviral reservoirs.
   AIDS. 2026 Feb 11. doi: 10.1097/QAD.0000000000004459.
   

   >> Share

   
   
3. LINDHARDT MS, Jensen LR, Meddis A, Gluud LL, et al
   Metabolic dysfunction-associated steatotic liver disease linked to antiretroviral exposure in cohort of people with HIV.
   AIDS. 2026 Feb 11. doi: 10.1097/QAD.0000000000004462.
   

   >> Share

   
   
4. NCHINDA N, Hemelaar J
   Neonatal mortality attributable to preterm births associated with maternal HIV infection in sub-Saharan Africa, 1990-2020.
   AIDS. 2026 Feb 11. doi: 10.1097/QAD.0000000000004463.
   

   >> Share

   
   
5. SCONZA R, Taylor GP, Ene L, Kahlert C, et al
   Dosing of ritonavir-boosted darunavir for treatment of HIV in pregnancy.
   AIDS. 2026 Feb 11. doi: 10.1097/QAD.0000000000004461.
   

   >> Share

   
   
6. MOUSSE AH, Bregigeon S, Hocqueloux L, Menard A, et al
   Factors associated with penicillin and sulfonamide allergy and Stevens-Johnson syndrome/toxic epidermal necrolysis.
   AIDS. 2026 Feb 9. doi: 10.1097/QAD.0000000000004457.
   

   >> Share

   
   
7. FLYNN DW, Fairhead C, Heath K, Hill A, et al
   HIV self-testing and clinician-administered testing in Southern Africa: a systematic review of programmatic outcomes.
   AIDS. 2026 Feb 10. doi: 10.1097/QAD.0000000000004458.
   

   >> Share

   
   

   
   AIDS Res Hum Retroviruses

8. CHEN M, Chen H, Ma Y, Jia M, et al
   Identification of a Novel HIV-1 Circulating Recombinant Form (CRF181_BC) with a Unique Subtype B Backbone from the China-Myanmar Border Region.
   AIDS Res Hum Retroviruses. 2026 Feb 6:8892229261423350.
   

   >> Share

   
   

   
   Am J Epidemiol

9. HABERLING DL, Ge L, Pondo T, Taylor MM, et al
   Applying Capture Recapture Methods to Estimate the Burden of Chlamydial and Gonococcal Infections Using Indian Health Service Medical Records, 2016-2021.
   Am J Epidemiol. 2026 Feb 10:kwag031. doi: 10.1093.
   

   >> Share

   
   

   
   Clin Infect Dis

10. BANOONI P, Gonik B, Epalza C, Reyes O, et al
    Efficacy, immunogenicity, and safety of an investigational maternal respiratory syncytial virus prefusion F protein-based vaccine.
    Clin Infect Dis. 2025 Jan 29:ciaf033. doi: 10.1093.
    

    >> Share

    
    
11. STREINU-CERCEL A, Castagna A, Chang SC, Chen YS, et al
    Efficacy and Safety of Obeldesivir in High-Risk Nonhospitalized Patients with COVID-19 (BIRCH): a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study.
    Clin Infect Dis. 2025 Jul 22:ciaf406. doi: 10.1093.
    

    >> Share

    
    
12. DE LAGARDE M, De Miguel R, Sigcha MA, Blanco JL, et al
    Impact of Proviral-DNA M184V/I on 96-Week Outcomes of DTG/3TC Maintenance Therapy: Results from the VOLVER Clinical Trial.
    Clin Infect Dis. 2026 Feb 10:ciag060. doi: 10.1093.
    

    >> Share

    
    
13. GREEN AS, Li JZ, Sax PE
    Is Two Drug Therapy with Dolutegravir and Lamivudine an Appropriate Option for People with HIV and Historic Lamivudine Resistance?
    Clin Infect Dis. 2026 Feb 10:ciag061. doi: 10.1093.
    

    >> Share

    
    
14. BIXLER D, Bennett CC, Yin S, Thomson A, et al
    Fatal Overdose, Acute Viral Hepatitis, and Human Immunodeficiency Virus Attributed to Injection Drug Use, Appalachian Region of the United States, 2000-2023.
    Clin Infect Dis. 2026 Feb 11:ciaf730. doi: 10.1093.
    

    >> Share

    
    
15. RUFFIEUX Y, Andoh J, Haas AD, Chinogurei C, et al
    Association of Immunodeficiency and HIV Viremia with Cervical Precancer and Cancer Risk among Women with HIV in South Africa.
    Clin Infect Dis. 2026 Feb 14:ciag093. doi: 10.1093.
    

    >> Share

    
    

    
    HIV Med

16. KOKORELIAS KM, Sheppard CL, Eaton A, Wasilewski MB, et al
    Understanding the implementation of patient navigation for adults living with HIV: A scoping review of components, equity considerations and lessons learned.
    HIV Med. 2026 Feb 9. doi: 10.1111/hiv.70194.
    

    >> Share

    
    
17. BALLENY R, Wong JMH, Lee T, Bitnun A, et al
    Perinatal and early infant outcomes after first-versus second-generation integrase strand transfer inhibitor use in pregnancy.
    HIV Med. 2026 Feb 10. doi: 10.1111/hiv.70206.
    

    >> Share

    
    
18. MOUSSE A, Allavena C, Gagneux-Brunon A, Raffi F, et al
    Calibration and discrimination ability of the Dat'AIDS score in people living with HIV aged 70 years and older from the Dat'AIDS cohort.
    HIV Med. 2026 Feb 11. doi: 10.1111/hiv.70207.
    

    >> Share

    
    
19. BARBER TJ, Akinosoglou K, Bernardino JI, Koppe U, et al
    Highlights from the 20th European AIDS Conference: 15-18 October 2025, Paris, France.
    HIV Med. 2026 Feb 12. doi: 10.1111/hiv.70195.
    

    >> Share

    
    

    
    Int J Dermatol

20. TANASOV A, Tiplica GS
    Sexually Transmitted Infection Prevalence and Determinants Among Sexual Health Clinic Attendees in Bucharest, Romania.
    Int J Dermatol. 2026 Feb 15. doi: 10.1111/ijd.70344.
    

    >> Share

    
    

    
    J Acquir Immune Defic Syndr

21. ERGUERA XA, Koester KA, Christopoulos KA
    Rethinking "Patient Preference" in Rapid ART: A Qualitative Reframing.
    J Acquir Immune Defic Syndr. 2026;101:e5-e6.
    

    >> Share

    
    
22. O'CONNOR L, Hammerlund S, Mele L, Castel A, et al
    Clinical and HIV Surveillance Data to Determine Care Status for People with HIV in Washington, DC.
    J Acquir Immune Defic Syndr. 2026 Feb 12. doi: 10.1097/QAI.0000000000003846.
    

    >> Share

    
    
23. EYNON N, Prasad K, Bassett H, Johnson J, et al
    "Optimizing STI prevention: barriers, behaviors, and broader impacts of doxycycline post-exposure prophylaxis (DoxyPEP)".
    J Acquir Immune Defic Syndr. 2026 Feb 12. doi: 10.1097/QAI.0000000000003849.
    

    >> Share

    
    
24. CUMMINGS TH, Magagnoli J, Sikirzhytskaya S, Tyagin I, et al
    Evaluating the Impact of Blood Brain Barrier-Penetrant ACE Inhibitors on HIV-Associated Neurocognitive Disorders.
    J Acquir Immune Defic Syndr. 2026 Feb 12. doi: 10.1097/QAI.0000000000003847.
    

    >> Share

    
    
25. GLICK JL, Nestadt DF, Sanchez T, Lucas IL, et al
    Intersectional stigma associations with long-acting injectable PrEP (LAI-PrEP) willingness and preference among cisgender gay, bisexual, and other men who have sex with men (GBMSM): A brief quantitative report.
    J Acquir Immune Defic Syndr. 2026 Feb 12. doi: 10.1097/QAI.0000000000003850.
    

    >> Share

    
    

    
    J Clin Invest

26. KIOKO M, Mwangi S, Fwambah L, Hassan AS, et al
    Variation in antiviral immunity and inflammation pathways precedes HIV-1 infection in a high-risk African cohort.
    J Clin Invest. 2026 Feb 12:e195172. doi: 10.1172/JCI195172.
    

    >> Share

    
    

    
    J Infect Dis

27. SHELLARD JPG, Carr E, Tam-McMillan G, Mao EW, et al
    Unsuppressed viraemia and lower CD4 count associated with faster telomere attrition in African children with perinatal HIV on long-term antiretroviral therapy.
    J Infect Dis. 2026 Feb 7:jiag060. doi: 10.1093.
    

    >> Share

    
    
28. NIETO RAMIREZ LM, Shelton K, Belisle JT, Diaz G, et al
    Optimized Mass Spectrometry to Uncover M. tuberculosis Biomarkers in Extracellular Vesicles from Asymptomatic Tuberculosis Patients.
    J Infect Dis. 2026 Feb 10:jiag086. doi: 10.1093.
    

    >> Share

    
    
29. CRONIN C, Sun J, Kizer JR, Wu KC, et al
    Mitochondrial Haplogroups and Left Ventricular Diastolic Dysfunction in People Living with and without HIV.
    J Infect Dis. 2026 Feb 11:jiag090. doi: 10.1093.
    

    >> Share

    
    

    
    Lancet

30. ORKIN C, Mngqibisa R, Velez JD, Kumar P, et al
    Switch to fixed-dose doravirine (100 mg) and islatravir (0.25 mg) once daily in virologically suppressed adults with HIV-1 on oral antiretroviral therapy: 48-week results of a phase 3, multicentre, randomised, open-label, non-inferiority trial.
    Lancet. 2026;407:599-610.
    

    >> Share

    
    
31. ESTRADA V, Cabello-Clotet N
    Beyond integrase: the rise of doravirine and islatravir in HIV management.
    Lancet. 2026;407:551-553.
    

    >> Share

    
    
32. COLSON AE, Mills AM, Ramgopal MN, Bettacchi C, et al
    Switch to fixed-dose doravirine (100 mg) and islatravir (0.25 mg) once daily in virologically suppressed adults with HIV-1 on bictegravir, emtricitabine, and tenofovir alafenamide: 48-week results of a phase 3, multicentre, randomised, controlled, dou
    Lancet. 2026;407:611-621.
    

    >> Share

    
    

    
    Nat Med

33. 
    PD-1 blockade reprograms antiviral immunity and reduces the HIV reservoir.
    Nat Med. 2026 Feb 12. doi: 10.1038/s41591-025-04152.
    

    >> Share

    
    
34. TALLA A, Azevedo JLLC, Latif MB, Enriquez AB, et al
    Innate antiviral and immune functions associated with the HIV reservoir decay after anti-PD-1 therapy.
    Nat Med. 2026 Feb 12. doi: 10.1038/s41591-025-04139.
    

    >> Share

    
    

    
    Pediatr Infect Dis J

35. NANTANEE R, Lolekha R, Lertpiriyasuwat C, Puangtaptim W, et al
    High Viral Suppression Rates and Attrition Rates Among Children With Perinatally Acquired HIV in the Thai National AIDS Program, 2023.
    Pediatr Infect Dis J. 2026;45:251-257.
    

    >> Share

    
    

    
    PLoS Med

36. DUROVNI B, Cordeiro-Santos M, Cavalcante SC, Spener-Gomes R, et al
    Acceptability and safety of one versus three months of rifapentine and isoniazid to prevent tuberculosis in people exposed in the household or workplace in Brazil: The Ultra-Curto randomized controlled trial.
    PLoS Med. 2026;23:e1004758.
    

    >> Share

    
    

    
    PLoS One

37. REZA MM, Shanto HH, Irfan SD, Rana AKMM, et al
    Prevalence and determinants of unintended pregnancy among female sex workers (FSW) in Jashore, Bangladesh.
    PLoS One. 2026;21:e0342766.
    

    >> Share

    
    
38. HORST C, Kitt H, Corkin H, Mullen D, et al
    Retrospective challenges to pre-exposure prophylaxis (PrEP) use among people living with HIV-A qualitative analysis using the COM-B framework.
    PLoS One. 2026;21:e0325871.
    

    >> Share

    
    
39. PEPRAH KG, Agbozo F, Kwabla MP, Tashie W, et al
    Prevalence and predictors of virological failure and quality of life of people with HIV/AIDS at a Municipal Hospital, Volta Region -Ghana: A cross-sectional study.
    PLoS One. 2026;21:e0329346.
    

    >> Share

    
    
40. HARSONO D, Sklar K, Silver M, Frederick M, et al
    Food insecurity and COVID-19-related experiences among people with HIV: A mixed methods analysis and conceptual framework.
    PLoS One. 2026;21:e0342667.
    

    >> Share

    
    
41. ABDULAI K, Osman Aleboko S, Anane I, Addae-Mensah I, et al
    Prevalence and determinants of hypertension among people living with HIV in Ghana: A cross-sectional study.
    PLoS One. 2026;21:e0342198.
    

    >> Share

    
    
42. STRAUSS M, Osman M, Meehan SA, Marx FM, et al
    An economic evaluation of the LINKEDin study: An intervention to reduce initial loss to follow-up among tuberculosis patients in South Africa.
    PLoS One. 2026;21:e0342708.
    

    >> Share

    
    
43. STRICKLER C, Thorball CW, Schoepf IC, Schwenke J, et al
    Association of a polygenic risk score with low trauma fractures in people with HIV - The swiss HIV cohort study.
    PLoS One. 2026;21:e0342748.
    

    >> Share

    
    
44. DO NASCIMENTO GOMES BRITO VC, de Souza Maximiano LC, de Andrade FB, de Abrantes RM, et al
    Sources of information on HIV/AIDS used by adolescents and young people: A scoping review protocol.
    PLoS One. 2026;21:e0340787.
    

    >> Share

    
    
45. NDLOVU Z, Nhandara R, Govender K, Mpande-Nyasulu F, et al
    Feasibility and testing outcomes of task-shared implementation of advanced HIV disease point of care tests in Beira (Mozambique) and Kinshasa (DRC).
    PLoS One. 2026;21:e0339469.
    

    >> Share

    
    

    
    Vaccine

46. STICCHI L, Di Biagio A, Domnich A, Inglese M, et al
    Immunogenicity and safety of two doses of the four-component recombinant meningococcal B (4CMenB) vaccine in adults with immunodeficiency.
    Vaccine. 2026;76:128295.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share